BlueStar Genomic Health Care Index

The BlueStar Genomic Health Care Index (BDNANTR) tracks the performance of the largest and most liquid companies in the global genomic healthcare industry. This is a modified market cap-weighted index, and only includes companies that generate at least 50% of their revenue from health care therapies based on targeting or the modification of the genetic makeup of cells or uses mRNA, technology platforms that enable the development of genetics-based health care thearpies, or laboratory equipment or services used to test, code, or develop genetics-based health care companies.

Country and Sector Weightings

MVIS Sector Indices are pure-play sector indices. Companies must generate at least 50% of their revenues in the target sector to be eligible for index inclusion. Country and Sector weightings are based on the weightings of all index components in a certain country or sector.

CountryComponentsWeight
Canada1 0.93%
United States62 78.52%
Belgium1 0.96%
France2 2.13%
Germany3 3.44%
Netherlands1 1.03%
Switzerland1 1.17%
United Kingdom4 5.03%
Israel1 1.14%
Japan2 2.09%
New Zealand1 1.51%
China2 2.04%
Total81 100.00%
SectorComponentsWeight
Health Care81 100.00%
Total81 100.00%

Size Weightings

  • Large-Cap: companies with a market capitalisation above 6,000 mln USD
  • Mid-Cap: companies with a market capitalisation from 1,500 mln to 6,000 mln USD
  • Small-Cap: companies with a market capitalisation from 200 mln to 1,500 mln USD
  • Micro-Cap: companies with a market capitalisation up to 200 mln USD
SizeMarket CapComponentsWeight
Large-Cap495,772,532,700 USD18 25.46%
Mid-Cap91,833,921,400 USD28 37.56%
Small-Cap30,169,921,640 USD35 36.98%
Micro-Cap---
Total617,776,375,740 USD81 100.00%
Up